Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Cash from Investing Activities (2019 - 2025)

Summit Therapeutics' Cash from Investing Activities history spans 7 years, with the latest figure at -$485.2 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 681.15% year-over-year to -$485.2 million; the TTM value through Dec 2025 reached -$174.3 million, up 15.11%, while the annual FY2025 figure was -$174.3 million, 15.11% up from the prior year.
  • Cash from Investing Activities reached -$485.2 million in Q4 2025 per SMMT's latest filing, down from -$71000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $160.1 million in Q1 2025 to a low of -$645.1 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is -$48.4 million, with a median of -$55000.0 recorded in 2021.
  • The largest YoY upside for Cash from Investing Activities was 605580.0% in 2023 against a maximum downside of 178587.81% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$120000.0 in 2021, then soared by 108.33% to $10000.0 in 2022, then soared by 605580.0% to $60.6 million in 2023, then surged by 37.83% to $83.5 million in 2024, then crashed by 681.15% to -$485.2 million in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Cash from Investing Activities are -$485.2 million (Q4 2025), -$71000.0 (Q3 2025), and $150.8 million (Q2 2025).